Switzerland· 57038011
Olmetec Plus 20/25, Filmtabletten
A olmesartan medoxomil und diuretika product containing olmesartanum medoxomilum, hydrochlorothiazidum, registered in Switzerland by Daiichi Sankyo (Schweiz) AG and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 12 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Olmesartan medoxomil und diuretika is registered in 12 of 19 countries.
Countries holding a registration under ATC C09DA08 (olmesartan medoxomil und diuretika), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 8 of them publish a price we can compare per daily dose
Olmesartan medoxomil und diuretika · ATC C09DA08
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
The record
At a glance
Swissmedic (Switzerland)- Active substance
- olmesartanum medoxomilum, hydrochlorothiazidum
- Manufacturer
- Daiichi Sankyo (Schweiz) AG
- Country
- Switzerland (CH)
- ATC code
- C09DA08
- ATC class
- Olmesartan medoxomil und Diuretika
- Swissmedic category
- B
- Reimbursed
- Yes
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin768057038011028 StkCHF 30
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
80 interactions on record for olmesartan medoxomil und diuretika.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Olmesartan medoxomil und diuretika · interactions on record
80 records
80 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame class
Other records under C09DA08
Olmesartan medoxomil und diuretika, as other registers publish it.
- CanadaACH-OLMESARTAN HCTZACCORD HEALTHCARE INC
- CanadaACH-OLMESARTAN HCTZACCORD HEALTHCARE INC
- CanadaACH-OLMESARTAN HCTZACCORD HEALTHCARE INC
- CanadaAPO-OLMESARTAN/HCTZAPOTEX INC
- CanadaAPO-OLMESARTAN/HCTZAPOTEX INC
- CanadaAPO-OLMESARTAN/HCTZAPOTEX INC
- CanadaAURO-OLMESARTAN HCTZAURO PHARMA INC
- CanadaAURO-OLMESARTAN HCTZAURO PHARMA INC
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/eb561a1a-b6cf-4168-81ad-e748c39381ea GET /v1/drugs/eb561a1a-b6cf-4168-81ad-e748c39381ea?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "olmesartani medoxomilum 20 mg + hydrochlorothiazidum 25 mg",
"valid_from": "2005-12-01",
"limitations": null,
"galenic_form": "Filmtabl 20/25",
"therapeutic_area": null,
"sl_inclusion_date": "2005-12-01",
"self_retention_pct": 10
}See everything about olmesartan medoxomil und diuretika.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.